Voya Financial Advisors, Inc. Charles River Laboratories International, Inc. Transaction History

Voya Financial Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $7,123 - $9,570	-35 Reduced 3.59%	939 $254,000
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $160,242 - $232,630	974 New	974 $230,000
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $181,505 - $207,727	988 New	988 $207,000
Q4 2022 Feb 14, 2023	SELL	$197.11 - $250.07 $75,690 - $96,026	-384 Reduced 25.05%	1,149 $250,000
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $7,115 - $9,771	39 Added 2.61%	1,533 $291,000
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $47,766 - $70,761	-234 Reduced 13.54%	1,494 $328,000
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $441,521 - $625,726	1,728 New	1,728 $501,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Voya Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Voya Financial Advisors, Inc. with notifications on news.